Author:
Blankestijn Peter J.,Bots Michiel L.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease study 2016. Lancet 390, 1345–1422 (2017).
2. de Jager, R. L. et al. Impact of medication adherence on the effect of renal denervation: the SYMPATHY trial. Hypertension 69, 678–684 (2017).
3. Gupta, P. et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension 69, 1113–1120 (2017).
4. Townsend, R. R. et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet
http://dx.doi.org/10.1016/S0140-6736(17)32281-X
(2017).
5. Spiering, W. et al. Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study. Lancet
http://dx.doi.org/10.1016/S0140-6736(17)32337-1
(2017).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献